Ex vivo drug screening informed targeted therapy for metastatic parotid squamous cell carcinoma

Published: 23 August 2021| Version 1 | DOI: 10.17632/9t7gn926ry.1
Contributor:
Juha Rantala

Description

Supplementary data files for Nykänen N et al. Supplementary data 1. GR metrics from the ex vivo drug sensitivity screening of sample A patient derived parotid SCC cells Supplementary data 2. GR metrics from the ex vivo drug sensitivity screening of sample B patient derived parotid SCC cells Supplementary data 3. RPPA assay results from the ex vivo drug sensitivity screening of sample B patient derived SCC cells

Files

Categories

High-Throughput Screening

Licence